Inobrodib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Inobrodib, covering 2026-04-22 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma [Phase 2]